CSIMarket
 
Cocrystal Pharma Inc   (NASDAQ: COCP)
Other Ticker:  
 
 
Price: $1.8300 $-0.06 -3.175%
Day's High: $1.87 Week Perf: -2.14 %
Day's Low: $ 1.81 30 Day Perf: -19.03 %
Volume (M): 15 52 Wk High: $ 3.26
Volume (M$): $ 28 52 Wk Avg: $1.91
Open: $1.87 52 Wk Low: $1.33



 Market Capitalization (Millions $) 19
 Shares Outstanding (Millions) 10
 Employees 12
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -17
 Cash Flow (TTM) (Millions $) -19
 Capital Exp. (TTM) (Millions $) 0

Cocrystal Pharma Inc
Cocrystal Pharma Inc. is a biopharmaceutical company located in Bothell, Washington. It was founded in 2014, and its mission is to develop novel antiviral therapeutics for the treatment of serious and life-threatening diseases. The company's focus is on developing products that target the replication of viruses inside the human body.

Cocrystal Pharma has developed a unique platform technology that enables the discovery of new drugs targeting viral replication, with the potential to transform the treatment of viral diseases. The company has a strong patent portfolio covering the composition of matter, formulation, and therapeutic use of its antiviral compounds.

Cocrystal Pharma's lead drug candidate is CC-31244, which is being developed as a treatment for influenza. The company is also developing other antiviral compounds, including CC-42344 for the treatment of hepatitis C and CC-82545 for the treatment of COVID-19.

In addition to its own drug development programs, Cocrystal Pharma has entered into collaborations with several pharmaceutical companies to leverage its platform technology for the discovery and development of new drugs. These collaborations include partnerships with Merck, Bristol-Myers Squibb, and Adimab.

The company's management team includes seasoned professionals with extensive experience in drug development and finance. Its Board of Directors includes prominent figures in the biotech and pharmaceutical industries, including Dr. Phillip Frost and Dr. Gary Wilcox.

Overall, Cocrystal Pharma is an innovative biopharmaceutical company focused on developing a new generation of antiviral drugs for the treatment of serious diseases. Its pipeline of drug candidates, strong patent portfolio, and experienced management team make it a promising player in the biotech industry.


   Company Address: 19805 North Creek Parkway Bothell 98011 WA
   Company Phone Number: 262-7123   Stock Exchange / Ticker: NASDAQ COCP


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABBV        0.24% 
JNJ        0.82% 
LLY        8.38% 
MRK   -12.54%    
OGN   -1.95%    
PFE   -1.76%    
• View Complete Report
   



Cocrystal Pharma Inc

Cocrystal Pharma Inc shines with outstanding second quarter performance in 2023, outshining competitors

Cocrystal Pharma Inc, a company operating in the Major Pharmaceutical Preparations industry, recently reported an operating deficit of $-4.339 million for the second quarter of fiscal year 2023, which ended on June 30. While this may seem like a negative outcome, it is important to note that Cocrystal Pharma Inc has actually performed significantly better compared to the same period last year, where they reported an operating deficit of $-24.428 million.
One of the most promising aspects of this earnings report is the reduction in returns from the second quarter of 2022 to the second quarter of 2023. The returns have diminished from $-24.428 million to $-4.166 million, indicating a substantial improvement in the company's performance. This positive trend suggests that Cocrystal Pharma Inc is on track to establish itself as a noteworthy leader in the pharmaceutical industry.










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com